BACES SCORE AND TREATMENT OUTCOMES IN PATIENTS WITH MYCOBACTERIUM AVIUM COMPLEX PULMONARY DISEASE

被引：0
|
作者：
Vadiyala, Mounika Reddy
Conley, Elyse
Arias-Sanchez, Pedro
Karnakoti, Snigdha
Marty, Paige
Pathakumari, Balaji
VanKeulen, Virginia
Peikert, Tobias
Ju, Nianqiao Phyllis
Pienaar, Elsje
Pennington, Kelly
Escalante, Patricio
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.662
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：887A / 888A
页数：2
相关论文
共 50 条
  • [21] The treatment outcomes of cavitary Mycobacterium avium complex pulmonary disease according to the use of amikacin or streptomycin
    Kim, Seong Min
    Shim, Tae Sun
    Jo, Kyung-Wook
    RESPIROLOGY, 2023, 28 : 204 - 204
  • [22] Treatment Outcomes of Clofazimine-Containing Regimens in Severe Mycobacterium avium Complex Pulmonary Disease
    Lee, Inhan
    Hwang, Eui Jin
    Kim, Joong-Yub
    Yim, Jae-Joon
    Kwak, Nakwon
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (02):
  • [23] Comparison of Treatment Outcomes of Cavitary Mycobacterium avium Complex Pulmonary Disease with Streptomycin or Amikacin Use
    Kim, Seong Min
    Chong, Yong Pil
    Lee, Hyun Joo
    Shim, Tae Sun
    Jo, Kyung-Wook
    MICROBIOLOGY SPECTRUM, 2023, 11 (03)
  • [24] Variables associated with antibiotic treatment tolerance in patients with Mycobacterium avium complex pulmonary disease
    Meghan Marmor
    Husham Sharifi
    Susan Jacobs
    Kiana Fazeli
    Stephen Ruoss
    Respiratory Research, 25
  • [25] Variables associated with antibiotic treatment tolerance in patients with Mycobacterium avium complex pulmonary disease
    Marmor, Meghan
    Sharifi, Husham
    Jacobs, Susan
    Fazeli, Kiana
    Ruoss, Stephen
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [26] PRESENCE OF GASTROESOPHAGEAL REFLUX DISEASE IS NOT ASSOCIATED WITH WORSE OUTCOMES IN PATIENTS WITH MYCOBACTERIUM AVIUM COMPLEX PULMONARY DISEASE
    Nihalani, Mayank
    Bosch, Wendelyn
    Johnson, Margaret
    Koop, Andree
    GASTROENTEROLOGY, 2024, 166 (05) : S1007 - S1007
  • [27] Clinical characteristics and early outcomes of patients newly diagnosed with pulmonary Mycobacterium avium complex disease
    Hagiwara, Eri
    Katano, Takuma
    Isomoto, Kohsuke
    Otoshi, Ryota
    Yamakawa, Hideaki
    Okuda, Ryo
    Sekine, Akimasa
    Baba, Tomohisa
    Komatsu, Shigeru
    Ogura, Takashi
    RESPIRATORY INVESTIGATION, 2019, 57 (01) : 54 - 59
  • [28] Familial pulmonary Mycobacterium avium complex disease
    Tanaka, E
    Kimoto, T
    Matsumoto, H
    Tsuyuguchi, K
    Suzuki, K
    Nagai, S
    Shimadzu, M
    Ishibatake, H
    Murayama, T
    Amitani, R
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (05) : 1643 - 1647
  • [29] Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
    Hyung-Jun Kim
    Jong Sik Lee
    Nakwon Kwak
    Jaeyoung Cho
    Chang-Hoon Lee
    Sung Koo Han
    Jae-Joon Yim
    BMC Pulmonary Medicine, 19
  • [30] Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease
    Deshpande, Devyani
    Srivastava, Shashikant
    Pasipanodya, Jotam G.
    Lee, Pooi S.
    Gumbo, Tawanda
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 : 30 - 35
12345